首页> 外文期刊>Neurocritical care >Prevalence of Previously Undiagnosed Abdominal Aortic Aneurysms in Patients with Intracranial Aneurysms: From the Brain and Aortic Aneurysms Study (BAAS)
【24h】

Prevalence of Previously Undiagnosed Abdominal Aortic Aneurysms in Patients with Intracranial Aneurysms: From the Brain and Aortic Aneurysms Study (BAAS)

机译:颅内动脉瘤患者以前未确诊的腹膜动脉瘤的患病率:来自脑和主动脉瘤研究(BAAS)

获取原文
获取原文并翻译 | 示例
           

摘要

Background A relationship between intracranial and abdominal aortic aneurysms (AAA) has been appreciated through genome-wide association studies suggesting a shared pathophysiology. However, the actual prevalence of AAA in patients presenting with ruptured intracranial aneurysms is not known. Our aim was to estimate the prevalence of previously undiagnosed AAA in patients presenting with aneurysmal subarachnoid hemorrhage (aSAH) to see if it may be high enough to justify formally testing the utility of screening. Methods A prospective, observational inception cohort study of 81 consecutive patients presenting to Mayo Clinic Florida with aSAH was performed from August 14, 2011 to February 10, 2014. These individuals were then screened using an abdominal ultrasound technique for an AAA. Our primary end point was detection of AAA. Our secondary end points were 30-day good-to-fair functional status (modified Rankin scale < 4) and all-cause mortality. Results We detected an AAA in 10 patients (rate: 12%; 95% CI 6-22%) with aSAH. The mean diameter of these AAA was 3.4 +/- 1.0 cm. Among these 10 patients, there was one death within the first month of aSAH hospitalization. There were no significant differences in demographic or clinical characteristics based on AAA detection status. Mean follow-up time was 4.7 years. The rate of good-to-fair functional status at 30-days was 79%. All-cause mortality during follow-up at 1-year was higher for patients with AAA (36%; 95% CI 0-61%) compared to patients without AAA (7%; 95% CI 1-14%) (log-rank p = 0.045). Conclusions The co-prevalence of AAA in patients presenting with ruptured brain aneurysms may be sufficiently high such that screening for AAA among likely survivors of aSAH might be appropriate. Larger studies would be needed to establish a net clinical benefit from screening AAA and then treating newly identified large AAAs in this morbid population.
机译:背景技术通过暗示致病病理生理学的基因组关联研究,已经理解颅内和腹主动脉瘤(AAA)之间的关系。然而,患有破裂颅内动脉瘤患者的AAA的实际患病率是不名的。我们的目的是估算患有动脉瘤蛛网膜膜瘤出血(ASAH)的患者患者以前未确诊的AAA的患病率,以了解它是否足够高,以正式测试筛选的效用。方法采取81例前瞻性患者的前瞻性观测成立队伙伴研究,将与Asah佛罗里达州佛罗里达州佛罗里达州的81名患者进行,从2011年8月14日至2014年2月10日进行。然后使用AAA的腹部超声技术筛选这些个体。我们的主要终点是检测AAA。我们的二级终点是30天的良好公平的功能状态(改进的Rankin Scale <4)和全导致死亡率。结果我们在10名患者中检测到AAA(率:12%; 95%CI 6-22%)。这些AAA的平均直径为3.4 +/- 1.0cm。在这10名患者中,Asah住院的第一个月内有一个死亡。基于AAA检测状态,人口统计学或临床特征没有显着差异。平均随访时间为4.7岁。 30天的良好公平功能状况的速度为79%。与没有AAA的患者相比,AAA患者的后续患者在1年的后续患者(365%; 95%CI 1-14%)(LOG-排名p = 0.045)。结论脑动脉瘤患者患者AAA的共育可能足够高,使得在ASAH的可能幸存者中筛查AAA可能是合适的。需要更大的研究来建立筛选AAA的净临床益处,然后在这种病态人群中治疗新鉴定的大型AAAs。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号